Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$336M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$149M |
| 3 |
Waste Management
WM
|
+$122M |
| 4 |
McDonald's
MCD
|
+$113M |
| 5 |
Eli Lilly
LLY
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Communication Services | 11.59% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THR
2376
DELISTED
Thermon Group Holdings
THR
| $1.25M | ﹤0.01% |
73,200
-2,600
| -3% | -$48.4K |
|
|
FFIC
2377
DELISTED
Flushing Financial
FFIC
| $1.24M | ﹤0.01% |
58,023
| – | – |
|
2378
DXP Enterprises
DXPE
$3.05B
| $1.24M | ﹤0.01% |
37,300
-900
| -2% | -$27.8K |
|
2379
Ennis
EBF
$553M
| $1.24M | ﹤0.01% |
57,500
-1,700
| -3% | -$35.9K |
|
|
ICPT
2380
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.24M | ﹤0.01% |
61,900
+2,200
| +4% | +$43.6K |
|
2381
Telos
TLS
$324M
| $1.24M | ﹤0.01% |
+36,300
| New | +$1.22M |
|
2382
BioXcel Therapeutics
BTAI
$32.7M
| $1.23M | ﹤0.01% |
2,650
+562
| +27% | +$306K |
|
|
HGEN
2383
DELISTED
HUMANIGEN, INC.
HGEN
| $1.23M | ﹤0.01% |
+70,900
| New | +$1.29M |
|
2384
Arrow Financial
AROW
$718M
| $1.23M | ﹤0.01% |
37,364
-1,311
| -3% | -$43K |
|
2385
Cass Information Systems
CASS
$735M
| $1.23M | ﹤0.01% |
30,152
+2,100
| +7% | +$94.5K |
|
|
WTRE
2386
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $1.23M | ﹤0.01% |
35,100
-3,100
| -8% | -$108K |
|
2387
Barrett Business Services
BBSI
$739M
| $1.23M | ﹤0.01% |
67,600
-1,600
| -2% | -$29.3K |
|
2388
Akebia Therapeutics
AKBA
$246M
| $1.22M | ﹤0.01% |
321,485
+7,700
| +2% | +$25.9K |
|
2389
V2X
VVX
$2.5B
| $1.22M | ﹤0.01% |
25,600
-700
| -3% | -$36K |
|
|
GOCO
2390
DELISTED
GoHealth
GOCO
| $1.22M | ﹤0.01% |
7,240
+893
| +14% | +$156K |
|
2391
Curis
CRIS
$4.79M
| $1.22M | ﹤0.01% |
+377
| New | +$1.7M |
|
2392
Midland States Bancorp
MSBI
$695M
| $1.21M | ﹤0.01% |
46,100
| – | – |
|
2393
Tootsie Roll Industries
TR
$2.95B
| $1.21M | ﹤0.01% |
41,370
-7,071
| -15% | -$199K |
|
2394
PC Connection
CNXN
$2.01B
| $1.2M | ﹤0.01% |
26,000
-700
| -3% | -$32.8K |
|
2395
Mercer International
MERC
$33M
| $1.2M | ﹤0.01% |
94,372
-3,000
| -3% | -$44.4K |
|
2396
ImmunityBio
IBRX
$8.08B
| $1.2M | ﹤0.01% |
84,100
+9,600
| +13% | +$159K |
|
|
NWLI
2397
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.2M | ﹤0.01% |
5,349
-100
| -2% | -$23.8K |
|
2398
Kymera Therapeutics
KYMR
$9.32B
| $1.2M | ﹤0.01% |
24,700
-500
| -2% | -$21.7K |
|
2399
Comstock Resources
CRK
$4.14B
| $1.2M | ﹤0.01% |
+179,300
| New | +$1.03M |
|
|
KE
2400
Kimball Electronics
KE
$615M
| $1.2M | ﹤0.01% |
55,000
-2,500
| -4% | -$56.3K |
|
Similar funds
Swiss National Bank's Q2 2021 Portfolio in Review
As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
- Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
- Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
- Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
- Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
- Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.